Menu

The Interview·Lesson 2.2·18 min read

The Knowledge You Need

The questions are designed so that you don't need knowledge beyond A-level. But that means the whole specification, understood well enough to reason from. There is also a set of ideas that tutors treat as basic for anyone going into medicine, mostly about evidence, that isn't on any A-level specification. This lesson covers:

  • The A-level core, and how to revise it for an interview rather than an exam
  • The principles that keep reappearing across topics
  • Study design, and how to measure risk and benefit
  • Which topics to know in depth beyond the syllabus, and where to read about them
  • The other knowledge you will need: your personal statement and the general interview questions
Section 2.2.1

The A-level core

If you know your A-level Biology and Chemistry thoroughly, you have the knowledge for nearly every science question. Download your exam board's specification and use it as a checklist: for each statement, ask whether you could explain it out loud accurately, and for the high-yield areas, why it happens (the first two levels in the next section). The table shows the areas that matter most and the direction interviews tend to take from each one. The right-hand column shows the kind of question to expect, not facts to learn.

AreaWhat to have secureWhere interviews take it
Cells and membranesMembrane structure, diffusion, osmosis, facilitated diffusion, active transport, receptors and cell signallingHow fast things move and what limits it; what happens when a channel or receptor is blocked
Molecules and enzymesProtein structure and folding, enzyme action and inhibition, ATPMaximum rates; drugs that act as inhibitors; where the energy comes from
GeneticsDNA structure, protein synthesis, the genetic code, mutation, inheritance and family trees, PCR and electrophoresisWhat different mutations do to a protein; why some alleles are dominant; the ethics of genetic testing
Nerves and muscleAction potentials, myelin, synapses, the neuromuscular junction, muscle contractionWhat a disease or drug does to one step, and the symptoms that follow
Heart and circulationThe cardiac cycle, pressures and valves, the ECG, blood vessels, tissue fluid, haemoglobinReading pressure traces and ECGs; what happens when a valve or vessel fails
LungsVentilation, gas exchange, surface areaCauses of breathlessness, and how to organise them
Kidneys and homeostasisFiltration, reabsorption, the loop of Henle, ADH, blood glucose control, negative feedbackWhat ends up in urine and why; how to measure kidney function; diabetes
Immunity and diseasePathogens, viruses, innate and adaptive immunity, antibodies, vaccines, antibioticsWhy some infections are severe; types of vaccine; resistance
Cell division and cancerThe cell cycle and its control, mitosis, mutation, uncontrolled growthHow cancers develop, how treatments target them, and how resistance arises
Acids, bases and equilibriapH, strong and weak acids, buffers, equilibrium and Le Chatelier's principleBlood pH, and which organs control which part of it
Energetics and kineticsEnthalpy, entropy, free energy, rates, activation energyHow a process can happen on its own; the effect of temperature
Bonding and organic chemistryPolarity, hydrogen bonding and other intermolecular forces, functional groups, reaction mechanismsWhy molecules dissolve or bind; drug and receptor shapes; a mechanism you haven't seen
Maths in scienceRates, gradients, logarithms, standard deviation, the statistical tests on your courseReading graphs, log scales, estimation

Gaps in your specification

Exam boards differ, and interviews are in December of Year 13, before you have finished the course. The kidney, the nervous system, muscle contraction, the immune system and thermodynamics are all covered in different depth by different boards, or taught late. Check each high-frequency area above against your own specification. If yours doesn't cover one, or you haven't reached it, read the relevant chapter from a textbook for another board. You only need the A-level version.

If you don't take A-level Physics, make sure your GCSE physics is secure: pressure, current, voltage and resistance, waves and radiation. Tutors utilise these ideas freely, especially in questions on circulation, nerves and imaging.

Section 2.2.2

Levels of understanding

Everything starts with knowing the A-level content accurately: what happens, in what order, with the right terms. That is the foundation, and it is the part to get completely secure, because you can't reason from knowledge you don't have. It helps to think of each topic at three levels.

LevelWhat it meansWhat to do with it
1: What happensThe A-level content: the facts, the sequence, the termsLearn it thoroughly, for every topic on your specification
2: Why it happensThe mechanism underneath: the gradient, the binding or the structure that explains the factThink it through for the high-yield topics in the table above, as far as A-level allows
3: What ifWhat happens when something changes: a part is blocked, missing, doubled or pushed to an extremeDon't try to learn it. Practise working it out from Levels 1 and 2

Level 3 is what interviews are made of, but there are far too many possible variations to learn, and tutors deliberately choose ones you won't have seen. What you can do is practise working them out. Once a topic is secure, pose a few "what if" questions and reason through them out loud, then check your reasoning against a textbook. For example, once you know how a nerve impulse travels, ask what would happen if the sodium-potassium pump stopped, or if a toxin blocked the sodium channels, and work it out rather than looking it up. Doing this across a range of topics builds the habit you will use in the room.

As you revise, notice that the same few principles keep appearing in different topics: gradients, saturation, feedback, binding, scale. They are listed in the next section. Linking topics through them is what lets you answer a question about a system you haven't studied.

Section 2.2.3

Common themes

Underneath the topics, interview questions reuse a small number of principles. If you recognise which one a question is about, an unfamiliar question often turns into a familiar one. When you are stuck, go through this list and ask which principle applies.

PrincipleThe ideaExample question themes
Gradients drive movementThings move down a gradient of concentration, pressure or charge, and a steeper gradient means faster movementDiffusion, gas exchange, filtration in the kidney, blood flow, ions crossing membranes
Opposing forces balanceAn equilibrium is where two tendencies cancel. Change one and the balance point movesResting membrane potentials, tissue fluid, chemical equilibria, buffers
SaturationAnything that depends on binding to a limited number of sites has a maximum rateEnzymes, carrier proteins, receptors, haemoglobin, the response to a drug dose
Specific bindingShape and chemistry decide what binds to what, and how tightlyEnzymes, receptors, antibodies, drugs, matching donors for transplants
Negative feedbackA change is detected and a response opposes it. When feedback fails, disease followsBlood glucose, water balance, blood pH, temperature, blood pressure
Structure fits functionEvery feature has a job. Asking what the job is usually explains the featureValves, myelin, alveoli, capillaries, protein shape
ScaleVolume grows faster than surface area, and diffusion is fast across a cell but hopelessly slow over centimetresWhy large organisms need a circulation, why cells are small, why lungs are folded
ConservationWhat goes in must come out, be stored or be destroyed. Concentration is amount divided by volumeMeasuring body fluid volumes and kidney function, dilution, drug doses
Trade-offsAlmost every biological feature and medical decision gains something and costs somethingHow harmful a pathogen is, test accuracy, treatment benefits and side effects, immunosuppression
SignallingInformation travels by nerves, hormones or direct contact, which differ in speed, reach and how long the effect lastsNervous and hormonal control; drugs that mimic or block a signal
Section 2.2.4

Study design

None of this is on the A-level specification, beyond basic experimental design, but it comes up often. Tutors are scientists and doctors, medicine depends on evidence, and any "how would you test that?" or "would you trust this result?" question needs it.

The central problem: does X cause Y?

Most medical research tries to answer whether something (a drug, a habit, an exposure) causes an outcome. When two things are found together, there are four explanations other than causation, and a good answer considers each.

  • Chance. In a small study, differences appear by luck. Larger studies and statistics deal with this.
  • Bias. A systematic error in who is studied or how things are measured. If people with a disease are asked to remember past exposures, they search their memories harder than healthy people do (recall bias). If the healthiest patients are the ones offered a new treatment, it will look better than it is (selection bias).
  • Confounding. A third factor linked to both. People who take vitamin supplements live longer, but they also tend to be richer, exercise more and smoke less. Any of those could explain the difference.
  • Reverse causation. The outcome causes the exposure. People who are losing weight are more likely to die soon, but often because an undiagnosed illness is causing the weight loss.

The main study types

DesignHow it worksStrengthsWeaknesses
Case report or seriesDescribes one patient, or a few, with something unusualSpots new diseases and rare side effects quickly and cheaplyNo comparison group, so it can't show cause
EcologicalCompares whole groups, such as countries or regions, rather than individualsCheap, uses existing data, good for generating ideasA pattern across countries may not hold for individuals; heavily confounded
Cross-sectionalMeasures exposure and outcome in a population at one point in time, as in a surveyQuick and cheap; shows how common something is (prevalence)Can't tell which came first
Case-controlStarts with people who have the disease (cases) and similar people who don't (controls), then looks back at past exposuresEfficient for rare diseases; quick; can study many exposures at onceRecall bias; choosing fair controls is hard; can't measure how often the disease occurs
CohortFollows a group over time, comparing those exposed and not exposed, to see who develops the outcomeExposure is measured before the outcome, so the order is clear; can study many outcomes; measures risk directlySlow and expensive; people drop out; still confounded; poor for rare diseases
Randomised controlled trial (RCT)Participants are randomly allocated to the treatment or a control, ideally without knowing which, and followed upRandomisation balances confounders, including unknown ones, so it gives the strongest evidence of causeExpensive and slow; strict entry criteria mean results may not apply to everyone; can't be used for harmful exposures
Systematic review and meta-analysisFinds every study on a question using a set method, and pools the resultsThe most complete and precise summary of the evidenceOnly as good as the studies it includes; affected by publication bias

Qualitative studies, which use interviews or focus groups, answer a different kind of question: why and how rather than how many. Why do patients stop taking a medicine? What is it like to live with dialysis?

How a new treatment is tested

A new drug passes through a series of trials before and after it is approved, each answering a different question.

Trial phasePurpose
Phase 1A small number of people, often healthy volunteers. Is it safe, and what dose?
Phase 2A few hundred patients. Does it seem to work, and what are the side effects?
Phase 3Hundreds to thousands of patients, compared with placebo or standard treatment. Does it work better, and is it safe enough to approve?
Phase 4After approval, monitoring in the general population for rare or long-term side effects

The hierarchy of evidence, and its limits

For questions about whether a treatment works, evidence is usually ranked by how well it protects against bias: systematic reviews of RCTs, then RCTs, then cohort studies, then case-control studies, then cross-sectional and ecological studies, then case reports and expert opinion.

The point that marks real understanding is that the best design depends on the question. You can't randomise people to smoke, so the evidence that smoking causes lung cancer comes from case-control and cohort studies. For a rare disease, a cohort study would need to follow enormous numbers of people, so a case-control study is the right tool. A first report of a new disease is a case series. If you are asked which design to use, start from what the question is and what would be ethical and practical, not from the top of the hierarchy.

What makes a trial fair

  • A control group. Without one you can't tell the effect of the treatment from what would have happened anyway. Many conditions improve on their own.
  • Placebo. People given an inactive treatment often improve, so a fair comparison is with a placebo, or with the current best treatment if one exists.
  • Randomisation. Allocating by chance means the groups differ only by chance, in things you have measured and things you haven't.
  • Blinding. If patients know which group they are in, their expectations affect results. If doctors know, their assessments can be biased. Double-blind means neither knows.
  • Enough participants. Small trials miss real effects and exaggerate chance ones. The number needed is calculated before the trial starts.
  • The right outcome, measured for long enough. It should be decided in advance and matter to patients. A drug that lowers blood pressure is useful only if it reduces strokes and heart attacks, and some effects take years to appear.
  • Intention to treat. Patients are analysed in the group they were allocated to, even if they stopped the treatment. Otherwise people who drop out because of side effects vanish from the results and the treatment looks better than it is.
  • Generalisability. Results from carefully selected volunteers may not apply to older patients or those with several conditions, who are often excluded.

Ethics of research

Participants give informed consent and can leave at any time. A trial is only ethical if there is genuine uncertainty about which option is better (equipoise). Studies are approved by an ethics committee, and an independent committee monitors results during a trial so it can be stopped early if one arm is clearly better or clearly harmful. A placebo should not be used where a proven treatment exists and withholding it would cause harm.

Statistics

You will have met p-values and confidence intervals at A-level, and they mean the same thing in a trial: a p-value below 0.05 means a difference this large would be unlikely if the treatment had no real effect, a confidence interval gives the range of plausible sizes for that effect, and a result can be statistically significant while being too small to matter to a patient.

Section 2.2.5

Measuring risk and benefit

Questions about treatments, trials and headlines depend on a few measures. Here is one example used throughout: over five years, 3% of people taking a placebo have a stroke, and 2% of people taking a new drug do.

MeasureHow it's calculatedIn the example
RiskNumber with the outcome ÷ number in the group3% on placebo, 2% on the drug
Absolute risk reduction (ARR)Risk without treatment − risk with treatment3% − 2% = 1 percentage point
Relative risk (RR)Risk with treatment ÷ risk without treatment2 ÷ 3 = 0.67
Relative risk reduction (RRR)ARR ÷ risk without treatment1 ÷ 3 = about 33%
Number needed to treat (NNT)1 ÷ ARR1 ÷ 0.01 = 100 people treated for five years to prevent one stroke

"Cuts stroke risk by a third" and "prevents one stroke for every hundred people treated" describe the same result. Relative figures sound larger and are the ones that appear in headlines and adverts. Absolute figures are what an individual patient needs to make a decision, especially when weighed against side effects (the number needed to harm is calculated the same way). The same relative reduction gives a much bigger absolute benefit to someone at high risk than to someone at low risk, which is why treatments are often targeted at high-risk groups.

Case-control studies can't measure risk, because the researchers chose how many cases to include. They report an odds ratio instead, which is close to the relative risk when the disease is rare.

Some other terms that come up:

  • Incidence is the number of new cases in a period. Prevalence is the number of people who have the condition at a given time. A disease that lasts a long time can have a high prevalence even if its incidence is low.
  • Rates need a population and a time period: deaths per 1,000 people per year, for example. Comparing raw numbers of cases between groups of different sizes is a common mistake.
  • Crude and age-standardised rates. A crude death rate depends heavily on how old a population is. Age-standardised rates adjust for this so that populations can be compared fairly.
  • Morbidity is illness, and mortality is death.
  • Life expectancy is calculated from the death rates at each age. A low average life expectancy can be driven largely by deaths in childhood.
Section 2.2.6

Going beyond the syllabus

Beyond the syllabus, aim to know one or two medical topics in real depth. Choose something you are genuinely interested in and immerse yourself in the science around it: how it works, what the evidence is, what is still unknown, and how it connects to the A-level content you already know. Depth comes across in an interview in a way that wide reading doesn't. An applicant who has followed one topic properly talks about it precisely, keeps reasoning when the tutor pushes past what they have read, and links it to other areas without being prompted.

These should be topics on your personal statement. Tutors read it, and often use something in it as the starting point for a question, so it is the one part of the interview you can predict. Anything you mention should be something you can discuss for ten minutes and reason about when the questions go further than your reading. The next section covers how to prepare each item on your statement.

Work through the sources in order, from the familiar to the specialist:

  1. 1.Your A-level textbook. Start with the relevant chapter, and the equivalent chapter from another exam board if it goes further. Make sure the basics are secure before moving on.
  2. 2.Writing for a general reader. A popular science book on the topic, or articles in magazines such as New Scientist or Scientific American, give the wider picture and the questions currently being asked.
  3. 3.A university textbook chapter or a review article. A review article summarises the research on one topic, and many can be read free through PubMed Central or Google Scholar. Read only the chapter or review on your topic, not the whole book.
  4. 4.One or two original research papers. Read the abstract, look at the figures, and ask the questions from the study design section: what kind of study it was, what was compared with what, and whether anything other than the authors' conclusion could explain the result.

By the end, for each topic, you should be able to explain the core science, the evidence for it, and one question that is still open.

Some things are not worth your time:

  • First-year university content in general. Tutors choose questions nobody at school could already know the answer to, and if they sense you know one, they simply move on. Reading one chapter on a topic you care about is different from trying to get ahead on the course.
  • Lists of diseases, drug names or unusual facts. If a question needs a specialist fact, the tutor will give it to you.
  • Model answers to specific questions. The questions change every year, and a memorised answer falls apart at the first follow-up.

Time spent on any of these is better spent securing the A-level core and practising reasoning from it out loud.

Section 2.2.7

Other knowledge you'll need

Not everything you need to know is science. Two other areas come up in almost every Oxbridge medicine interview: your personal statement, which follows on from the reading above, and the general questions every medical school asks. Neither needs much explanation here, but both need to be part of your preparation from the start.

Your personal statement

Assume that anything in your personal statement can become the anchor for a science question: if you mention a book about antibiotic resistance, expect to be asked how resistance develops. For each book, project, EPQ or piece of work experience, prepare four things:

  • What it was, in two sentences
  • The one idea from it you found most interesting, and the science behind that idea
  • Something that surprised you, or that you disagree with, and why
  • A question it left you with

If there is anything you couldn't talk about for five minutes, find out more about it now.

The general interview questions

Questions on why you want to study medicine, ethical scenarios, the NHS and your work experience come up at both universities. At Cambridge they often have an interview of their own, and at Oxford they are usually part of each interview. Panels usually include a practising doctor, and Cambridge lists "awareness of the major current issues facing the NHS" among the things its interviewers assess. Don't treat this as secondary: prepare as thoroughly as you would for any other medical school interview. Our lessons on motivation for medicine, ethical questions, NHS and topical issues and work experience cover it, and you need it for your other three interviews anyway.

The difference at Oxbridge is that tutors follow up. Expect "why do you think that?" and "what would you say to someone who disagreed?" Prepared answers that you can't defend or extend do more harm than good, so focus on understanding your own views rather than memorising how to phrase them.